Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 19 de 19 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia. A nested case-control study. JAMA Intern Med 2019:24 de junio. [Ref.ID 103160]
2. Cita con resumen
Coupland C, Hill T, Morriss R, Moore M, Arthur A, Hippisley-Cox J. Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database. BMJ 2016;352:i1350. [Ref.ID 100143]
3. Cita con resumen
Anónimo. QT interval and drug therapy. Drug Ther Bull 2016;54:33-6. [Ref.ID 100134]
4. Cita con resumen
Hatcher S, Arroll B. Newer antidepressants for the treatment of depression in adults. BMJ 2012;344:45-9. [Ref.ID 92299]
6.
Madhusoodanan S, Bogunovic OJ, Moise D, Brenner R, Markowitz S, Sotelo J. Hyponatraemia associated with psychotropic medications: a review of the literature and spontaneous reports. Adverse Drug React Toxicol Rev 2002;21:17-29. [Ref.ID 62070]
7. Cita con resumen
Hippisley-Cox J, Pringle M, Hammersley V, Crown N, Wynn A, Meal A, Coupland C. Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care. BMJ 2001;323:666-9. [Ref.ID 59214]
8. Cita con resumen
Anónimo. The drug treatment of depression in primary care. MeReC Bulletin 2000;11:33-6. [Ref.ID 54639]
9.
Parikh C. Antidepressants in the elderly: challenges for study design and their interpretation. Br J Clin Pharmacol 2000;49:539-47. [Ref.ID 51149]
10.Tiene citas relacionadas Cita con resumen
Po A L W. Antidepressants and upper gastrointestinal bleeding. BMJ 1999;319:1081-2. [Ref.ID 47353]
11. Cita con resumen
Spigset O, Martensson B. Drug treatment of depression. BMJ 1999;318:1188-91. [Ref.ID 44920]
12. Cita con resumen
Yoshioka K, Kosasayama A, Yoshida M, Toshikura M, Nasu K, Funabashi S, Yamada A, Okada S. Post marketing surveillance of 13 products: safety and effectiveness. Pharmacoepidemiol Drug Saf 1999;8:31-43. [Ref.ID 43143]
13.
Ohayon MM, Caulet M, Priest R G, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998;51:273-83. [Ref.ID 37182]
14.
Anónimo. New drug therapies in multiple sclerosis. Scrip 1997;2227:21. [Ref.ID 32088]
16. Cita con resumen
Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995;310:221-5. [Ref.ID 23458]
17.
Anónimo. Update of antidepressants: lofepramine, amoxapine and viloxazine. Drug Ther Bull 1990;28:82-4. [Ref.ID 15733]
19.
Bateman DN, Chaplin S. Centrally acting drugs. BMJ 1988;296:417-9. [Ref.ID 12220]
Seleccionar todas
 
 1 a 19 de 19